News

Cocrystal Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to ...
There are currently no approved vaccines or treatments for norovirus infectionCocrystal’s CDI-988 is the first antiviral for ...
Assuming a partnership or other funding, Vaxart plans to conduct a Phase 2b safety and immunogenicity study that could ...
Utah health officials are investigating a norovirus outbreak in Utah County connected to frozen half-shell oysters from the South Korea. | Matt Rourke, AP The Utah Department of Health and Human ...
Canada is a major oyster supplier to the US, but regulatory inaction and oversights are harming both diners and oyster ...
The University regularly tests wastewater from 26 sewage junctions in 10 student residential buildings for SARS-CoV-2, influenza A and norovirus. The early warning system was originally implemented in ...
Every year, Minnesotans sit down to share meals and enjoy some tasty food and friendship. But for about one in six of us, that meal might come with a side effect we didn’t order—food poisoning, or a ...
Medical Device Network on MSN

FDA clears Qiagen’s next-gen syndrome panel

"FDA clears Qiagen’s next-gen syndrome panel" was originally created and published by Medical Device Network, a GlobalData ...
Moderna, Inc. ( NASDAQ: MRNA) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 10:00 AM EDT All right. Great. Thanks for joining us, everybody. I'm Terence Flynn, Morgan ...
Cocrystal Pharma ( ($COCP) ) has issued an update. Cocrystal Pharma announced that its President and co-CEO, Dr. Sam Lee, presented the company’s ...
Foodborne pathogens are on the rise — and they’re making people unwell. According to the most recent data from FoodNet, the authoritative source for tracking foodborne illnesses run by the Centers for ...